Genome-wide association studies (GWASs) have linked genetic variants to neuropsychiatric disorders, but their regulatory roles in non-coding regions remain largely unclear. Using the LUHMES neuronal ...

Parkinson's disease, a common neurodegenerative ailment, affects roughly 1 % of the population aged 60 and up, and the number of cases is anticipated to quadruple by 2040, posing a significant ...

Researchers from Shibaura Institute of Technology have designed and synthesized novel vitamin K analogues conjugated with retinoic acid, which exhibit potent neuronal differentiation-inducing ...

Analysis of gene expression signatures in prostate cancer prior to liver metastases. Analysis of distinct genomic, transcriptomic, and immune landscapes driven by alterations in androgen production, ...

BrainXell today announced the launch of its human induced pluripotent stem cell (iPSC)-derived sensory neurons, a scalable human cellular platform engineered to support reproducible functional studies ...

A new study led by scientists from the Hebrew University of Jerusalem and INSERM identified genes essential for turning embryonic stem cells into brain cells, including a gene linked to a previously ...

Efforts to efficiently manufacture human neurons from induced pluripotent stem cells (iPSCs) are rapidly transforming the landscape of neuroscience research, drug discovery, and emerging cell-based ...

Creative Biolabs launches expanded iPSC and astrocyte differentiation services to support next‑generation disease modeling and neurobiology research.

Neurodegenerative diseases like Parkinson's and Alzheimer's are characterized by irreversible neuron damage and limited natural repair mechanisms. While stem cell therapy holds great promise for ...